These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35957592)

  • 1. Normalized Theta but Increased Gamma Activity after Acetylcholinesterase Inhibitor Treatment in Alzheimer's Disease: Preliminary qEEG Study.
    Fide E; Yerlikaya D; Öz D; Öztura İ; Yener G
    Clin EEG Neurosci; 2023 May; 54(3):305-315. PubMed ID: 35957592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.
    Moss DE; Perez RG
    Curr Alzheimer Res; 2021; 18(13):1010-1022. PubMed ID: 34911424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.
    Almkvist O; Jelic V; Amberla K; Hellström-Lindahl E; Meurling L; Nordberg A
    Dement Geriatr Cogn Disord; 2001; 12(1):22-32. PubMed ID: 11125238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer's disease.
    Babiloni C; Lizio R; Del Percio C; Marzano N; Soricelli A; Salvatore E; Ferri R; Cosentino FI; Tedeschi G; Montella P; Marino S; De Salvo S; Rodriguez G; Nobili F; Vernieri F; Ursini F; Mundi C; Richardson JC; Frisoni GB; Rossini PM
    J Alzheimers Dis; 2013; 34(4):1015-35. PubMed ID: 23340039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer's Disease.
    Musaeus CS; Engedal K; Høgh P; Jelic V; Mørup M; Naik M; Oeksengaard AR; Snaedal J; Wahlund LO; Waldemar G; Andersen BB
    J Alzheimers Dis; 2018; 64(4):1359-1371. PubMed ID: 29991135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
    Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO
    J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
    Giacobini E; Spiegel R; Enz A; Veroff AE; Cutler NR
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1053-65. PubMed ID: 12111443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
    Meghdadi AH; Stevanović Karić M; McConnell M; Rupp G; Richard C; Hamilton J; Salat D; Berka C
    PLoS One; 2021; 16(2):e0244180. PubMed ID: 33544703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease.
    Jelic V; Dierks T; Amberla K; Almkvist O; Winblad B; Nordberg A
    Neurosci Lett; 1998 Sep; 254(2):85-8. PubMed ID: 9779926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients.
    Darreh-Shori T; Hellström-Lindahl E; Flores-Flores C; Guan ZZ; Soreq H; Nordberg A
    J Neurochem; 2004 Mar; 88(5):1102-13. PubMed ID: 15009666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative EEG and dynamic susceptibility contrast MRI in Alzheimer's disease: a correlative study.
    Mattia D; Babiloni F; Romigi A; Cincotti F; Bianchi L; Sperli F; Placidi F; Bozzao A; Giacomini P; Floris R; Grazia Marciani M
    Clin Neurophysiol; 2003 Jul; 114(7):1210-6. PubMed ID: 12842717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Pharmacological Treatments in Alzheimer's Disease: Permutation Entropy-Based EEG Complexity Study.
    Fide E; Polat H; Yener G; Özerdem MS
    Brain Topogr; 2023 Jan; 36(1):106-118. PubMed ID: 36399219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting-state EEG alpha/theta power ratio discriminates early-onset Alzheimer's disease from healthy controls.
    Özbek Y; Fide E; Yener GG
    Clin Neurophysiol; 2021 Sep; 132(9):2019-2031. PubMed ID: 34284236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer's disease.
    Atukeren P; Cengiz M; Yavuzer H; Gelisgen R; Altunoglu E; Oner S; Erdenen F; Yuceakın D; Derici H; Cakatay U; Uzun H
    Biomed Pharmacother; 2017 Jun; 90():786-795. PubMed ID: 28427041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients.
    Babiloni C; Del Percio C; Bordet R; Bourriez JL; Bentivoglio M; Payoux P; Derambure P; Dix S; Infarinato F; Lizio R; Triggiani AI; Richardson JC; Rossini PM
    Clin Neurophysiol; 2013 May; 124(5):837-50. PubMed ID: 23098644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency power and coherence of electroencephalography are correlated with the severity of Alzheimer's disease: A multicenter analysis in Taiwan.
    Chen CC; Hsu CY; Chiu HW; Hu CJ; Lee TC
    J Formos Med Assoc; 2015 Aug; 114(8):729-35. PubMed ID: 23969043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors.
    Sayer R; Law E; Connelly PJ; Breen KC
    Clin Biochem; 2004 Feb; 37(2):98-104. PubMed ID: 14725939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. qEEG as Biomarker for Alzheimer's Disease: Investigating Relative PSD Difference and Coherence Analysis.
    Simfukwe C; Han SH; Jeong HT; Youn YC
    Neuropsychiatr Dis Treat; 2023; 19():2423-2437. PubMed ID: 37965528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linarin improves the dyskinesia recovery in Alzheimer's disease zebrafish by inhibiting the acetylcholinesterase activity.
    Pan H; Zhang J; Wang Y; Cui K; Cao Y; Wang L; Wu Y
    Life Sci; 2019 Apr; 222():112-116. PubMed ID: 30802512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease.
    Patel A; Shah D; Patel Y; Patel S; Mehta M; Bambharoliya T
    Curr Drug Targets; 2023; 24(3):225-246. PubMed ID: 36515018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.